MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Hackensack Meridian Health
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
Novartis
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Gilead Sciences
M.D. Anderson Cancer Center
Baptist Health South Florida
Institute of Hematology & Blood Diseases Hospital, China
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
University of California, Irvine
National Institutes of Health Clinical Center (CC)
Nantes University Hospital
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
City of Hope Medical Center
Medical College of Wisconsin
Fred Hutchinson Cancer Center
Nantes University Hospital
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
University of Illinois at Chicago
Masonic Cancer Center, University of Minnesota
Weill Medical College of Cornell University
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
French Innovative Leukemia Organisation
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Children's Hospital Medical Center, Cincinnati
Thomas Jefferson University
Northside Hospital, Inc.
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Sanofi